These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10367499)

  • 1. Do entheogen-induced mystical experiences boost the immune system? Psychedelics, peak experiences, and wellness.
    Roberts TB
    Adv Mind Body Med; 1999; 15(2):139-47. PubMed ID: 10367499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Gratuitous Grace: The Influence of Religious Set and Intent on the Psychedelic Experience.
    Neitzke-Spruill L; Glasser C
    J Psychoactive Drugs; 2018; 50(4):314-321. PubMed ID: 30052496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of religiousness in the prediction and interpretation of mystical experiences in a sensory deprivation context: activation of religious schemas.
    Granqvist P; Larsson M
    J Psychol; 2006 Jul; 140(4):319-27. PubMed ID: 16967739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
    Lyvers M; Meester M
    J Psychoactive Drugs; 2012; 44(5):410-7. PubMed ID: 23457892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why revelations have occurred on mountains? Linking mystical experiences and cognitive neuroscience.
    Arzy S; Idel M; Landis T; Blanke O
    Med Hypotheses; 2005; 65(5):841-5. PubMed ID: 16054773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland.
    Kangaslampi S; Hausen A; Rauteenmaa T
    J Psychoactive Drugs; 2020; 52(4):309-318. PubMed ID: 32511073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
    Johnson MW; Hendricks PS; Barrett FS; Griffiths RR
    Pharmacol Ther; 2019 May; 197():83-102. PubMed ID: 30521880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of consciousness and mystical-type experiences after acute LSD in humans.
    Liechti ME; Dolder PC; Schmid Y
    Psychopharmacology (Berl); 2017 May; 234(9-10):1499-1510. PubMed ID: 27714429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychedelics and quasi-mystical experiences].
    Szummer C
    Lege Artis Med; 2012 Feb; 22(2):154-7. PubMed ID: 23057252
    [No Abstract]   [Full Text] [Related]  

  • 10. LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model.
    Wießner I; Falchi M; Palhano-Fontes F; Feilding A; Ribeiro S; Tófoli LF
    Psychol Med; 2023 Mar; 53(4):1151-1165. PubMed ID: 34253268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.
    Barrett FS; Griffiths RR
    Curr Top Behav Neurosci; 2018; 36():393-430. PubMed ID: 28401522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naturalistic use of psychedelics is related to emotional reactivity and self-consciousness: The mediating role of ego-dissolution and mystical experiences.
    Orłowski P; Ruban A; Szczypiński J; Hobot J; Bielecki M; Bola M
    J Psychopharmacol; 2022 Aug; 36(8):987-1000. PubMed ID: 35475373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique.
    Mosurinjohn S; Roseman L; Girn M
    Front Psychiatry; 2023; 14():1077311. PubMed ID: 37181886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mystical experience in the context of health care.
    Witte AS; van der Wal DM; Steyn HC
    J Holist Nurs; 2008 Jun; 26(2):84-92. PubMed ID: 18539874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy.
    Hendricks PS
    Int Rev Psychiatry; 2018 Aug; 30(4):331-342. PubMed ID: 30260256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.
    Barrett FS; Johnson MW; Griffiths RR
    J Psychopharmacol; 2015 Nov; 29(11):1182-90. PubMed ID: 26442957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychobiology of drug-induced religious experience: from the brain "locus of religion" to cognitive unbinding.
    Nencini P; Grant KA
    Subst Use Misuse; 2010 Nov; 45(13):2130-51. PubMed ID: 20388013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving.
    Sweat NW; Bates LW; Hendricks PS
    J Psychoactive Drugs; 2016; 48(5):344-350. PubMed ID: 27719438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies.
    Stocker K; Hartmann M; Ley L; Becker AM; Holze F; Liechti ME
    J Psychopharmacol; 2024 Jan; 38(1):80-100. PubMed ID: 37905369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Subjective Effects of Psychedelics within and Beyond WEIRD Contexts.
    Graziosi M; Singh M; Nayak SM; Yaden DB
    J Psychoactive Drugs; 2023; 55(5):558-569. PubMed ID: 37679890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.